Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer

Overview of attention for article published in European Journal of Pharmaceutical Sciences, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 2 X users

reddit: 1 Redditor

Readers on

mendeley: 21 Mendeley

You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Article details
Title	Functional characterization and development of novel human kinase insert domain receptor chimeric antigen receptor T-cells for immunotherapy of non-small cell lung cancer
Published in	European Journal of Pharmaceutical Sciences, November 2022
DOI	10.1016/j.ejps.2022.106331
Pubmed ID	36384203
Authors	Ming Zhong, Ghanbar Mahmoodi Chalbatani, Meifang Deng, Qiuyi Li, Elahe Gharagouzloo, Michael R Hamblin, Eloah Rabello Suarez, Lili Hu, Dingding Wang

View on publisher site Alert me about new mentions

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Geographical breakdown

Geographical breakdown
Country	Count	As %
United States	1	50%
Unknown	1	50%

Demographic breakdown

Type
Type	Count	As %
Science communicators (journalists, bloggers, editors)	1	50%
Members of the public	1	50%

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Geographical breakdown
Country	Count	As %
Unknown	21	100%

Demographic breakdown

Readers by professional status
Readers by professional status	Count	As %
Student > Bachelor	3	14%
Student > Master	3	14%
Researcher	2	10%
Other	1	5%
Unknown	12	57%

Readers by discipline
Readers by discipline	Count	As %
Medicine and Dentistry	3	14%
Pharmacology, Toxicology and Pharmaceutical Science	2	10%
Biochemistry, Genetics and Molecular Biology	2	10%
Computer Science	1	5%
Unknown	13	62%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 November 2022.

All research outputs

#16,063,069

of 25,392,582 outputs

Outputs from European Journal of Pharmaceutical Sciences

#1,906

of 2,951 outputs

Outputs of similar age

#215,177

of 433,571 outputs

Outputs of similar age from European Journal of Pharmaceutical Sciences

#23

of 55 outputs

Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.

So far Altmetric has tracked 2,951 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.

Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,571 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.

We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.